Newsmeme!
Discover News you didn't know existed
Accounting practices have matured, but there are still plenty of ways that companies can disguise their financial results.
Gold traded mostly slightly higher in Asia and London and spiked up to as high as $1079.05 just before 8AM EST before it fell back to $1070.73 by around 10AM EST, but it then rose to a new session high of $1082.93 by early afternoon and ended not far from that high with a gain of 1.05%. Silver jumped to as high as $15.367 and dropped back down to $15.19 before it climbed to a new high of $15.572 ...
Feb. 9 (Bloomberg) -- Natural gas futures declined for a second day on anticipation that supplies of the heating and industrial fuel will be adequate to meet winter heating demand.
PALM oil advanced yesterday, poised for the longest rally in more than two months, on speculation that stockpiles in Malaysia may have declined. April-delivery futures rose 0.4 per cent to close at RM2,561 ringgit a metric ton on the Malaysia Derivatives Exchange.
CPO FUTURES PALM oil advanced yesterday, poised for the longest rally in more than two months, on speculation that stockpiles in Malaysia may have declined. April-delivery futures rose 0.and#65300; per cent to close at RM2,561 ringgit a metric ton on the Malaysia Derivatives Exchange. The most-active contract rose for a sixth day, the longest gain since the period to November 18, 2009, according ...
Echo Therapeutics, Inc. , a company developing the needle-free Symphony⢠tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system and the Prelude⢠SkinPrep System for transdermal drug delivery, announced today that Patrick T.
RALEIGH, N.C.----Martin Marietta Materials, Inc. today announced results for the fourth quarter and year ended December 31, 2009, and provided a preliminary outlook for 2010. Notable items were:
Cynosure, Inc. , a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced financial results for the three and 12 months ended December 31, 2009.
PATTERSON, N.Y. -- Penwest Pharmaceuticals Co. today announced that it has initiated a Phase IIa clinical trial for A0001 in patients with the A3243G mitochondrial DNA point mutation and evidence of impaired mitochondrial function. This point mutation is commonly associated with MELAS syndrome. The study is being conducted at the Newcastle upon Tyne Hospitals in Newcastle, England. Newcastle is ...
The Government starts 2010 with a very full programme of reform in front of it. Our eyes will be firmly on the economy this year as we continue to implement our economic plan.
Related News Resources:
> HGH News
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |